MacuLogix
Harrisburg
About MacuLogix
MacuLogix focuses on detecting and tracking age-related macular degeneration. It leverages the science of dark adaptation to help eliminate preventable blindness caused by AMD. Through its AdaptDx® dark adaptometer, MacuLogix enables eye care professionals to detect, monitor, and start treating AMD three years before it can be seen in order to prevent vision loss.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $64.3M
- Funding stage: M&A
- Last round: Series D (Mar 2019)
- Website: maculogix.com
- Phone: 717-583-1220
Industries & Categories
Health Care, Health Diagnostics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/maculogix-24879 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.